Testimonies, Speeches and Comments
The NCPA has a highly effective office in Washington, D.C. that sponsors Capitol Hill briefings, conferences and testimony by NCPA experts before congressional committees. The NCPA serves as a source of "outside the Beltway" thinking for Capitol Hill deliberations.
Mar 19, 2009
I am Terry Neese, a distinguished fellow at the National Center for Policy Analysis and "serial entrepreneur." NCPA is a nonprofit, nonpartisan public policy research organization dedicated to developing and promoting private alternatives to government regulation and control. We provide policy ideas that help women, families and small businesses remain an active, productive part of our economy, solving public policy problems by relying on the strength of the competitive, entrepreneurial private sector.
Mar 12, 2009
Mr. Chairman and members of the Subcommittee, please accept my comments for the record regarding the March 12 hearing on the effects of climate change legislation on low and moderateincome families. I am Dr. Sterling Burnett, a senior fellow of the National Center for Policy Analysis, a nonprofit, nonpartisan public policy research organization dedicated to developing and promoting private alternatives to government regulation and control, solving problems by relying on the strength of the competitive, entrepreneurial private sector.
Mar 12, 2009
When I moved to Texas in 1991, someone gave me a little book of Texas wisdom titled, "Don't Squat with Your Spurs On." Among its nuggets of wisdom was this one: "No matter who says what, if it don't make sense, don't believe it." What's been going on with mark-to-market accounting doesn't make sense to me.
Feb 04, 2009
This Committee knows better than most that small business employees are much less likely to have access to employer-sponsored health coverage than the employees of larger firms. According to the Kaiser Family Foundation...
Jan 29, 2009
The market for medical care does not work like other markets. Providers typically do not disclose prices prior to treatment because they do not compete for patients based on price. Payments are usually not made by patients themselves but by third parties - employers, insurance companies or government.